Promotion of microtubule assembly in vitro by taxol
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PTX is a member of taxanes family, which arrest cells in the G2/M phase by binding to the β-tubulin subunits, inhibiting depolymerization of microtubules and cause apoptosis through cell-signaling cascades [3].”
In the citing paper
“The binding of paclitaxel counters the conformational effect of GTP-hydrolysis on microtubules, stabilizing microtubules against depolymerization.69,70”
From Electronic energy migration in microtubules (2023) · cites this paper as [69]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,073
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Microtubule Assembly in the Absence of Added Nucleotides
Shelanski, M. L., Gaskin, F., & Cantor, C. R. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.3.765 · Cited by 2,053
Microtubule Formation in vitro in Solutions Containing Low Calcium Concentrations
Weisenberg, R. C. (1972) · Science · doi:10.1126/science.177.4054.1104 · Cited by 1,210
Turbidimetric studies of the in vitro assembly and disassembly of porcine neurotubules
Gaskin, F., Cantor, C. R., & Shelanski, M. L. (1974) · Journal of Molecular Biology · doi:10.1016/0022-2836(74)90048-5 · Cited by 816
A theory of linear and helical aggregations of macromolecules
Oosawa, F., & Kasai, M. (1962) · Journal of Molecular Biology · doi:10.1016/s0022-2836(62)80112-0 · Cited by 766
Corliss, J. O., Inoue, S., & Stephens, R. E. (1977) · Transactions of the American Microscopical Society · doi:10.2307/3226119 · Cited by 763
Head to tail polymerization of actin
Wegner, A. (1976) · Journal of Molecular Biology · doi:10.1016/s0022-2836(76)80100-3 · Cited by 707
Opposite end assembly and disassembly of microtubules at steady state in vitro
Margolis, R. L., & Wilson, L. (1978) · Cell · doi:10.1016/0092-8674(78)90132-0 · Cited by 570
Research works printed but not linked: 3
- Schiff, P. B., Fant, J., Auster, L. A. & Horwitz, S. B. J. supramolec. Struct. 8, Suppl. 2, 328 (1978).
- Gaskin, F. & Shelanski, M. L. Essays Biochem. 12, 115–146 (1976).
- Borisy, G. G., Olmstead, J. B., Marcum, J. M. & Allen, C. Fedn Proc. 33, 167–174 (1974).
Cited by
Items 301–400 of 1,008
Natural Compounds as Modulators of Cell Cycle Arrest: Application for Anticancer Chemotherapies
Bailon-Moscoso, N., Cevallos-Solorzano, G., Romero-Benavides, J., & Ramirez Orellana, M. (2017) · Current Genomics · doi:10.2174/1389202917666160808125645 · Cited by 171
“The C-terminal domain of the MAP interacts with tubulin, while the N-terminal domain can bind with cellular vesicles, intermediate filaments or other microtubules [276, 280, 282, 336].”
BackgroundInfluentialp53-independent apoptosis induced by paclitaxel through an indirect mechanism
Lanni, J. S., Lowe, S. W., Licitra, E. J., Liu, J. O., & Jacks, T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9679 · Cited by 172
Motzer, R. J., Bajorin, D. F., Schwartz, L. H., Hutter, H. S., Bosl, G. J., Scher, H. I., Lyn, P., & Fischer, P. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.11.2277 · Cited by 176
Xu, Q., Liu, Y., Su, S., Li, W., Chen, C., & Wu, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.012 · Cited by 174
“Paclitaxel (PTX), a major chemotherapeutic drug extracted from the bark of Taxus brevifolia, is widely used to treat patients with lung, ovarian, breast cancer and advanced forms of Kaposi’s sarcoma [1,2].”
BackgroundAdvances in the chemistry of ?-lactam and its medicinal applications
Kamath, A., & Ojima, I. (2012) · Tetrahedron · doi:10.1016/j.tet.2012.07.090 · Cited by 173
Paclitaxel Nanocrystals for Overcoming Multidrug Resistance in Cancer
Liu, Y., Huang, L., & Liu, F. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100012s · Cited by 168
“Paclitaxel (PTX) is a potent antineoplastic agent against a wide variety of malignancies [1].”
BackgroundPaclitaxel And Docetaxel Resistance: Molecular Mechanisms and Development of New Generation Taxanes
Galletti, E., Magnani, M., Renzulli, M. L., & Botta, M. (2007) · ChemMedChem · doi:10.1002/cmdc.200600308 · Cited by 164
Plant Cell Culture for Production of Paclitaxel and Other Taxanes.
Zhong, J. (2002) · Journal of Bioscience and Bioengineering · doi:10.1016/s1389-1723(02)80200-6 · Cited by 173
Motwani, M., Delohery, T. M., & Schwartz, G. K. (1999) · PubMed · Cited by 173
Paclitaxel Prodrugs: Toward Smarter Delivery of Anticancer Agents
Skwarczynski, M., Hayashi, Y., & Kiso, Y. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0602155 · Cited by 170
Kanda, Y., Nakamura, H., Umemiya, S., Puthukanoori, R. K., Appala, V. R. M., Gaddamanugu, G. K., Paraselli, B. R., & Baran, P. S. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c03592 · Cited by 172
Paclitaxel (Taxol): An Inhibitor of Angiogenesis in a Highly Vascularized Transgenic Breast Cancer
Lau, D. H., Xue, L., Young, L. J. T., Burke, P. A., & Cheung, A. (1999) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.1999.14.31 · Cited by 172
Taxane-induced nail changes: incidence, clinical presentationand outcome
Minisini, A. M., Tosti, A., Sobrero, A. F., Mansutti, M., Piraccini, B. M., Sacco, C., & Puglisi, F. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg050 · Cited by 169
“Taxanes exert their cytotoxic effect by reversibly binding the β-subunit of tubulin, thereby inducing tubulin polymerization and inhibiting microtubule depolymerization [3, 4].”
BackgroundPrimary ovarian cancer chemotherapy: current standards of care
McGuire, W. P., & Markman, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601494 · Cited by 166
“These agents promote the assembly of microtubules and inhibit depolymerisation; and this action (unique to the taxanes) disturbs mitosis in normal and malignant cells (Schiff et al, 1979).”
BackgroundHall, D. G., Manku, S., & Wang, F. (2001) · Journal of Combinatorial Chemistry · doi:10.1021/cc0001001 · Cited by 170
Taxol: The chemistry and structure-activity relationships of a novel anticancer agent
Kingston, D. G. I. (1994) · Trends in Biotechnology · doi:10.1016/0167-7799(94)90120-1 · Cited by 169
Ettinger, D. S., Finkelstein, D. M., Sarma, R. P., & Johnson, D. H. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.6.1430 · Cited by 171
Conforti, F., Ioele, G., Statti, G. A., Marrelli, M., Ragno, G., & Menichini, F. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2008.08.004 · Cited by 167
Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review
Picard, M., & Castells, M. C. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-014-8416-0 · Cited by 169
“It exerts its antineoplastic effects by interfering with the dynamics of microtubules (components of the cell cytoskeleton) thereby causing mitotic block and cell death [9, 10].”
BackgroundTLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer
Rajput, S., Volk-Draper, L. D., & Ran, S. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1019 · Cited by 165
Taxol Neuropathy: Electrodiagnostic and Sural Nerve Biopsy Findings
Sahenk, Z. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540190110024 · Cited by 163
Membrane-less microfiltration using inertial microfluidics
Warkiani, M. E., Tay, A. K. P., Guan, G., & Han, J. (2015) · Scientific Reports · doi:10.1038/srep11018 · Cited by 162
Pang, Y., An, B., Lou, L., Zhang, J., Yan, J., Huang, L., Li, X., & Yin, S. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00480 · Cited by 161
Taxol-induced flexibility of microtubules and its reversal by MAP-2 and Tau.
Dye, R. B., Fink, S. P., & Williams, R. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53113-6 · Cited by 161
Magnify is a universal molecular anchoring strategy for expansion microscopy
Klimas, A., Gallagher, B. R., Wijesekara, P., Fekir, S., DiBernardo, E. F., Cheng, Z., Stolz, D. B., Cambi, F., Watkins, S. C., Brody, S. L., et al. (2023) · Nature Biotechnology · doi:10.1038/s41587-022-01546-1 · Cited by 169
“Taxol is a chemotherapeutic agent that can bind to β -tubulin subunits to stabilize microtubules, preventing their dissociation via Ca 2+ or cold temperature in vitro, halting microtubule dynamics that play am important role in mitosis, motility and cell growth and survival[37, 38, 39].”
Changing strategies in natural products chemistry
Cordell, G. A. (1995) · Phytochemistry · doi:10.1016/0031-9422(95)00444-c · Cited by 164
Adsorption of Taxol into Ordered Mesoporous Silicas with Various Pore Diameters
Hata, H., Saeki, S., Kimura, T., Sugahara, Y., & Kuroda, K. (1999) · Chemistry of Materials · doi:10.1021/cm981061n · Cited by 167
Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines.
Martello, L. A., McDaid, H. M., Regl, D. L., Yang, C. P., Meng, D., Pettus, T. R. R., Kaufman, M. D., Arimoto, H., Danishefsky, S. J., Smith, A. B., et al. (2000) · PubMed · Cited by 201
Self-citationCharacterization of the Taxol Binding Site on the Microtubule
Rao, S., He, L., Chakravarty, S., Ojima, I., Orr, G. A., & Horwitz, S. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.37990 · Cited by 164
Self-citationPhase II trial of docetaxel in patients with platinum-refractory advanced ovarian cancer.
Francis, P., Schneider, J., Hann, L., Balmaceda, C., Barakat, R., Phillips, M., & Hakes, T. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.11.2301 · Cited by 167
Rethinking production of Taxol® (paclitaxel) using endophyte biotechnology
Kusari, S., Singh, S., & Jayabaskaran, C. (2014) · Trends in biotechnology · doi:10.1016/j.tibtech.2014.03.011 · Cited by 165
Yan, J., Chen, J., Zhang, S., Hu, J., Huang, L., & Li, X. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00021 · Cited by 164
“In recent decades, a large number of natural products have been identified to interfere with the tubulin-microtubule system.(8) Combretastatin A-4 (CA-4), one of”
BackgroundClinical Pharmacokinetics of Paclitaxel
Sonnichsen, D. S., & Relling, M. V. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199427040-00002 · Cited by 163
Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel
Chou, T.-C., Zhang, X.-G., Harris, C. R., Kuduk, S. D., Balog, A., Savin, K. A., Bertino, J. R., & Danishefsky, S. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15798 · Cited by 163
Vallee, R. B. (1986) · Methods in Enzymology · doi:10.1016/0076-6879(86)34078-3 · Cited by 162
Recent advances in biosynthesis of bioactive compounds in traditional Chinese medicinal plants
Yang, L., Yang, C., Li, C., Zhao, Q. J., Liu, L., Fang, X., & Chen, X. (2015) · 中国科学通报:英文版 · doi:10.1007/s11434-015-0929-2 · Cited by 172
“The anti-mitotic and cytotoxic properties of taxol are derived from its activity in disrupting normal tubulin dynamics, leading to dysfunction of microtubules [115].”
BackgroundHuang, Y., Johnson, K. R., Norris, J. S., & Fan, W. (2000) · PubMed · Cited by 174
Bcl-2 Down-Regulation Is a Novel Mechanism of Paclitaxel Resistance
Ferlini, C., Raspaglio, G., Mozzetti, S., Distefano, M., Filippetti, F., Martinelli, E., Ferrandina, G., Gallo, D., Ranelletti, F. O., & Scambia, G. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.1.51 · Cited by 160
“The first taxane introduced in cancer therapy was paclitaxel, firstly isolated from Taxus brevifolia (Schiff et al., 1979).”
BackgroundMANGATAL, L., Adeline, M., Guénard, D., Guéritte, F., & Potìer, P. (1989) · Tetrahedron · doi:10.1016/s0040-4020(01)81313-2 · Cited by 162
Parthenogenesis and cytoskeletal organization in ageing mouse eggs
Webb, M., Howlett, S. K., & Maro, B. (1986) · Development · doi:10.1242/dev.95.1.131 · Cited by 162
Separating the effects of nucleotide and EB binding on microtubule structure
Zhang, R., LaFrance, B., & Nogales, E. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802637115 · Cited by 160
Moradi, M. M., Carson, L. F., Twiggs, L. B., Weinberg, J. B., Haney, A. F., & Ramakrishnan, S. (1993) · Cancer · doi:10.1002/1097-0142(19931015)72:8<2433::aid-cncr2820720822>3.0.co;2-l · Cited by 145
The Mode of Action of Taxol: Apoptosis at Low Concentration and Necrosis at High Concentration
Yeung, T. K., Germond, C., Chen, X., & Wang, Z. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1375 · Cited by 160
Stent development and local drug delivery
Regar, E., Sianos, G., & Serruys, P. W. (2001) · British Medical Bulletin · doi:10.1093/bmb/59.1.227 · Cited by 158
Hugdahl, J. D., & Morejohn, L. C. (1993) · PLANT PHYSIOLOGY · doi:10.1104/pp.102.3.725 · Cited by 160
Boehmerle, W., Huehnchen, P., Peruzzaro, S., Balkaya, M., & Endres, M. (2014) · Scientific Reports · doi:10.1038/srep06370 · Cited by 170
Thermal Enhancement of New Chemotherapeutic Agents at Moderate Hyperthermia
Mohamed, F., Marchettini, P., Stuart, O. A., Urano, M., & Sugarbaker, P. H. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.08.006 · Cited by 158
“Annals of Surgical Oncology, 10(4):463–468”
Crossin, K. L., & Carney, D. H. (1981) · Cell · doi:10.1016/0092-8674(81)90417-7 · Cited by 159
A phosphoglycoprotein associated with taxol resistance in J774.2 cells.
Roy, S. N., & Horwitz, S. B. (1985) · PubMed · Cited by 158
Self-citationCyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites
Buey, R. M., Calvo, E., Barasoain, I., Pineda, O., Edler, M. C., Matesanz, R., Cerezo, G., Vanderwal, C. D., Day, B. W., Sorensen, E. J., et al. (2007) · Nature Chemical Biology · doi:10.1038/nchembio853 · Cited by 156
“Cyclostreptin blocks binding of taxoid-site ligands We examined competition among taxoid-site ligands having different affinities for microtubules (discodermolide (3), epothilone B (4), epothilone A (5), cyclostreptin and paclitaxel (6); Kd at 35 1C of 0.”
BackgroundAnticancer and Antifungal Compounds from Aspergillus, Penicillium and Other Filamentous Fungi
Bladt, T. T., Frisvad, J. C., Knudsen, P. B., & Larsen, T. O. (2013) · Molecules · doi:10.3390/molecules180911338 · Cited by 158
“7 μM, respectively, and against leukemia in mice P-388 with LD50 values of 63–125 mg/kg [148,149].”
BackgroundSymmetry, equivalence, and molecular self-assembly
Workum, K. V., & Douglas, J. F. (2006) · Physical Review E · doi:10.1103/physreve.73.031502 · Cited by 167
Rose, P. G., Blessing, J. A., Ball, H. G., Hoffman, J. S., Warshal, D. P., DeGeest, K., & Moore, D. H. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(02)00091-4 · Cited by 156
Mitosis in a cell with multiple centrioles.
Ring, D., Hubble, R., & Kirschner, M. W. (1982) · The Journal of Cell Biology · doi:10.1083/jcb.94.3.549 · Cited by 156
Hari, M., Loganzo, F., Annable, T., Tan, X., Musto, S., Morilla, D. B., Nettles, J. H., Snyder, J. P., & Greenberger, L. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0190 · Cited by 175
“The taxane paclitaxel binds to microtubules and inhibits their disassembly (1).”
BackgroundBogdan, C., & Ding, A. (1992) · Journal of Leukocyte Biology · doi:10.1002/jlb.52.1.119 · Cited by 155
An Investigation into the Cytotoxicity and Mode of Action of Some Novel N-Alkyl-Substituted Isatins
Vine, K. L., Locke, J. M., Ranson, M., Pyne, S. G., & Bremner, J. B. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0704189 · Cited by 155
Bioactive Agents from Natural Sources: Trends in Discovery and Application
Grabley, S., & Thiericke, R. (1999) · Advances in biochemical engineering, biotechnology · doi:10.1007/3-540-49811-7_4 · Cited by 182
Antin, P. B., Forry‐Schaudies, S., Friedman, T. M., Tapscott, S. J., & Holtzer, H. (1981) · The Journal of Cell Biology · doi:10.1083/jcb.90.2.300 · Cited by 155
Menendez, J. A., Vellon, L., Mehmi, I., Teng, P. K., Griggs, D. W., & Lupu, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208238 · Cited by 154
“M and ultimately, triggers apoptosis (Schiff et al., 1979; Parness and Horwitz, 1981; Blagosklonny et al., 1995, 1996; Blagosklonny and Fojo, 1999).”
BackgroundSynthetic Systems Powered by Biological Molecular Motors
Saper, G., & Hess, H. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00249 · Cited by 149
Chemotherapy of Metastatic Breast Cancer: What to Expect in 2001 and Beyond
Esteva, F. J., Valero, V., Pusztai, L., Michaud, L. B., Buzdar, A. U., & Hortobágyi, G. N. (2001) · The Oncologist · doi:10.1634/theoncologist.6-2-133 · Cited by 154
“Both agents bind reversibly to the beta subunit of tubulin and induce tubulin polymerization [ 25 ].”
BackgroundFeldweg, A. M., Lee, C.-W., Matulonis, U. A., & Castells, M. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.11.043 · Cited by 154
Kurtz, J. M., Amalric, R., Brandone, H., Ayme, Y., Jacquemier, J., Pietra, J.-C., Hans, D., Pollet, J.-F., Bressac, C., & Spitalier, J.-M. (1989) · Cancer · doi:10.1002/1097-0142(19890515)63:10<1912::aid-cncr2820631007>3.0.co;2-y · Cited by 423
Modulation of Microtubule Dynamics by Drugs. A Paradigm for the Actions of Cellular Regulators.
Wilson, L., Panda, D., & Jordan, M. A. (1999) · Cell Structure and Function · doi:10.1247/csf.24.329 · Cited by 153
Boehmerle, W., Splittgerber, U., Lazarus, M. B., McKenzie, K. M., Johnston, D. G., Austin, D. J., & Ehrlich, B. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607240103 · Cited by 153
Yang, Y., Zhao, H., Barrero, R. A., Zhang, B., Sun, G., Wilson, I. W., Xie, F., Walker, K. D., Parks, J. W., Bruce, R., et al. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-69 · Cited by 161
“It can inhibit the division of actively growing tumor cells by preventing microtubule depolymerization [3] and has become increasingly important in the treatment of a”
BackgroundSelection of mammalian cells based on their cell-cycle phase using dielectrophoresis
Kim, U., Shu, C., Dane, K. Y., Daugherty, P. S., Wang, J. Y. J., & Soh, H. T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708760104 · Cited by 151
Mesoporous silica nanoparticles as potential carriers for enhanced drug solubility of paclitaxel
He, Y., Liang, S., Long, M., & Xu, H. X. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.04.049 · Cited by 151
Molecular Glue Discovery: Current and Future Approaches
Dewey, J. A., Delalande, C., Azizi, S.-A., Lu, V., Antonopoulos, D., & Babnigg, G. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00449 · Cited by 138
Smith, R. E., Brown, A. M., Mamounas, E. P., Anderson, S., Lembersky, B. C., Atkins, J. H., Shibata, H. R., Báez, L., DeFusco, P. A., Davila, E., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3403 · Cited by 151
Aneuploidy: a report of an ECETOC task force
Aardema, M. J. (1998) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(97)00029-x · Cited by 151
Chandrasekar, B., & Tanguay, J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00596-3 · Cited by 150
“to inhibition of cell replication (101).”
Luo, T. L., Wang, J., Yin, Y., Hua, H., Jing, J., Sun, X., Li, M., Zhang, Y., & Jiang, Y. (2010) · Breast Cancer Research · doi:10.1186/bcr2473 · Cited by 152
“The mechanism of action of taxol is a premature stabilization of microtubule assembly, which disrupts the cytoskeletal framework necessary for tumor-cell replication and metastatic spread [4].”
BackgroundKellogg, D. R., Field, C. M., & Alberts, B. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.109.6.2977 · Cited by 150
Ignea, C., Trikka, F. A., Nikolaidis, A. K., Georgantea, P., Ioannou, E., Loupassaki, S., Kefalas, P., Kanellis, A. K., Roussis, V., Makris, A. M., et al. (2014) · Metabolic Engineering · doi:10.1016/j.ymben.2014.10.008 · Cited by 152
Docetaxel enhances tumor radioresponse in vivo.
Mason, K. A., Hunter, N. R., Milas, M., Abbruzzese, J. L., & Milas, L. (1997) · PubMed · Cited by 149
Taxanes: an overview of the pharmacokinetics and pharmacodynamics
Vaishampayan, U. N., Parchment, R. E., Jasti, B., & Hussain, M. (1999) · Urology · doi:10.1016/s0090-4295(99)00451-3 · Cited by 149
A β-Tubulin Leucine Cluster Involved in Microtubule Assembly and Paclitaxel Resistance
Gonzalez-Garay, M. L., Chang, L., Cabral, F., Blade, K., & Menick, D. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.23875 · Cited by 146
Back to the tubule: microtubule dynamics in Parkinson’s disease
Pellegrini, L., Wetzel, A., Grannó, S., Heaton, G., & Harvey, K. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2351-6 · Cited by 137
Structure of GABARAP in Two Conformations
Coyle, J. E., Qamar, S., Rajashankar, K. R., & Nikolov, D. B. (2002) · Neuron · doi:10.1016/s0896-6273(01)00558-x · Cited by 145
“(Schiff et al., 1979).”
Expression of class III β‐tubulin reduces microtubule assembly and confers resistance to paclitaxel
Hari, M., Yang, H., Zeng, C., Canizales, M., & Cabral, F. (2003) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.10132 · Cited by 148
Nicolaou, K. C., Vourloumis, D., Li, T., Pastor, J., Winssinger, N., He, Y., Ninkovic, S., Sarabia, F., Vallberg, H., Roschangar, F., et al. (1997) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199720971 · Cited by 148
Biomolecular motors at the intersection of nanotechnology and polymer science
Agarwal, A., & Hess, H. (2009) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2009.10.007 · Cited by 157
“by the addition of paclitaxel (taxol) to the buffer solution [71].”
BackgroundLee, J. Y., Carugo, D., Crake, C., Owen, J., Victor, M. D. S., Seth, A., Coussios, C. C., & Stride, E. (2015) · Advanced Materials · doi:10.1002/adma.201502022 · Cited by 147
Seagull, R. W. (1990) · PROTOPLASMA · doi:10.1007/bf01326634 · Cited by 147
Cantù, M. G., Buda, A. A., Parma, G., Rossi, R., Floriani, I., Bonazzi, C. M., Dell’Anna, T., Torri, V., & Colombo, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1232 · Cited by 147
Sati, P., Sharma, E., Dhyani, P., Attri, D. C., Rana, R., Kiyekbayeva, L. N., Büsselberg, D., Samuel, S. M., & Sharifi‐Rad, J. (2024) · European journal of medical research · doi:10.1186/s40001-024-01657-2 · Cited by 161
“Interestingly, PTX stabilized microtubule formation in vitro and was resistant to low-temperature or calcium-triggered depolymerization [34, 90].”
BackgroundOne-step purification of assembly-competent tubulin from diverse eukaryotic sources
Widlund, P. O., Podolski, M., Reber, S., Alper, J., Storch, M., Hyman, A. A., Howard, J., & Drechsel, D. N. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-06-0444 · Cited by 141
“Consistent with their roles in chromosome segregation and cell division, microtubules are targeted by a number of anticancer drugs in the taxane and vinca alkaloid family (Schiff et al., 1979).”
BackgroundNatural antitubulin agents: Importance of 3,4,5-trimethoxyphenyl fragment
Negi, A. S., Gautam, Y., Alam, S., Chanda, D., Luqman, S., Sarkar, J., Khan, F., & Konwar, R. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.12.027 · Cited by 151
Wang, Y., Liu, X., Sun, T., Xiong, M., & Wang, J. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.01.021 · Cited by 151
Yap, W. N., Chang, P., Han, H., Lee, D. T. W., Ling, M. T., Wong, Y. C., & Yap, Y. L. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604763 · Cited by 144
“Natural products have historically been a rich source of biologically active compounds for drug discovery (Schiff et al, 1979).”
BackgroundA systematic review of platinum and taxane resistance from bench to clinic: An inverse relationship
Stordal, B., Pavlakis, N., & Davey, R. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.07.013 · Cited by 144
Fast Kinetics of Taxol Binding to Microtubules
Dı́az, J. F., Barasoain, I., & Andreu, J. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211163200 · Cited by 134
Kroep, J. R., Giaccone, G., Voorn, D. A., Smit, E. F., Beijnen, J. H., Rosing, H., van Moorsel, C. J. A., van Groeningen, C. J., Postmus, P. E., Pinedo, H. M., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2190 · Cited by 144
Morejohn, L. C., & Fosket, D. E. (1984) · Science · doi:10.1126/science.224.4651.874 · Cited by 144
Merrick, S. E., Trojanowski, J. Q., & Lee, V. M.-Y. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05726.1997 · Cited by 143
Borzilleri, R. M., Zheng, X., Schmidt, R. J., Johnson, J. A., Kim, S., DiMarco, J. D., Fairchild, C. R., Gougoutas, J. Z., Lee, F. Y., Long, B. H., et al. (2000) · Journal of the American Chemical Society · doi:10.1021/ja001899n · Cited by 143
The Microtubule-destabilizing Activity of Metablastin (p19) Is Controlled by Phosphorylation
Horwitz, S. B., Shen, H. J., He, L., Dittmar, P., Neef, R., Chen, J., & Schubart, U. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8129 · Cited by 143
Self-citationNovel molecules that interact with microtubules and have functional activity similar to Taxol™
He, L., Orr, G. A., & Horwitz, S. B. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02038-4 · Cited by 165
Self-citation
Metadata
- Authors
- SCHIFF, P. B., FANT, J., & HORWITZ, S. B.
- Affiliations
- Albert Einstein College of Medicine (US)
- ORCID
- SCHIFF, PETER B.
- Venue
- Nature
- Published
- 1979-02
- Volume
- 277
- Issue
- 5698
- Pages
- 665-667
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2067299834
- Cited by
- 3,600
- References
- 18
- Citations by year
- 2026: 50 · 2025: 68 · 2024: 72 · 2023: 86 · 2022: 89 · 2021: 93 · 2020: 67 · 2019: 83 · 2018: 84 · 2017: 86 · 2016: 90 · 2015: 99 · 2014: 105 · 2013: 105 · 2012: 102
- FWCI
- 13.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- paclitaxel, microtubule assembly, tubulin, Taxus brevifolia, HeLa cells, cell cycle arrest, G2/M block, antitumour activity, colchicine, podophyllotoxin, microtubule depolymerization, critical concentration
- MeSH terms
- Animals, Antineoplastic Agents, Phytogenic, Calcium, Cattle, Cold Temperature, Glycoproteins, Kinetics, Microtubules, Molecular Weight, Protein Binding, Terpenes, Tubulin, Macromolecular Substances
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.